Maximus, Inc. (NYSE:MMS) Given a $66.00 Price Target at Maxim Group
Maxim Group set a $66.00 price objective on Maximus, Inc. (NYSE:MMS) in a research note published on Thursday morning. The brokerage currently has a hold rating on the health services provider’s stock.
Several other research analysts have also weighed in on the company. Zacks Investment Research raised Maximus from a sell rating to a hold rating in a research report on Wednesday, July 26th. BidaskClub lowered Maximus from a hold rating to a sell rating in a research report on Monday, July 24th. Canaccord Genuity lowered Maximus from a buy rating to a hold rating and set a $62.00 target price on the stock. in a research report on Tuesday, July 4th. KeyCorp reaffirmed a sector weight rating on shares of Maximus in a research report on Thursday, May 25th. Finally, ValuEngine lowered Maximus from a buy rating to a hold rating in a research report on Tuesday, May 16th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating and one has issued a buy rating to the stock. The stock currently has an average rating of Hold and a consensus target price of $62.17.
Maximus (NYSE:MMS) traded up 0.16% during trading on Thursday, hitting $61.06. The stock had a trading volume of 648,089 shares. The company has a market cap of $3.96 billion, a P/E ratio of 19.57 and a beta of 1.39. The company has a 50 day moving average of $61.91 and a 200-day moving average of $60.73. Maximus has a 12-month low of $43.69 and a 12-month high of $64.97.
Maximus (NYSE:MMS) last issued its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, topping the consensus estimate of $0.76 by $0.03. Maximus had a return on equity of 25.08% and a net margin of 8.43%. The company had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. During the same period in the prior year, the firm posted $0.79 EPS. The business’s revenue was down 2.7% compared to the same quarter last year. On average, equities analysts predict that Maximus will post $3.06 EPS for the current year.
COPYRIGHT VIOLATION NOTICE: This report was originally published by Daily Political and is the sole property of of Daily Political. If you are reading this report on another website, it was illegally stolen and reposted in violation of U.S. & international trademark and copyright legislation. The legal version of this report can be read at https://www.dailypolitical.com/2017/08/06/maximus-inc-nysemms-given-a-66-00-price-target-at-maxim-group.html.
The business also recently declared a quarterly dividend, which will be paid on Thursday, August 31st. Stockholders of record on Tuesday, August 15th will be paid a dividend of $0.045 per share. The ex-dividend date is Friday, August 11th. This represents a $0.18 annualized dividend and a dividend yield of 0.29%. Maximus’s dividend payout ratio (DPR) is presently 5.73%.
In other news, Director Russell A. Beliveau sold 1,500 shares of the company’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $63.82, for a total transaction of $95,730.00. Following the completion of the sale, the director now owns 41,829 shares in the company, valued at approximately $2,669,526.78. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, President Bruce Caswell sold 17,197 shares of the company’s stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $62.47, for a total value of $1,074,296.59. Following the sale, the president now owns 27,904 shares of the company’s stock, valued at approximately $1,743,162.88. The disclosure for this sale can be found here. In the last quarter, insiders have sold 117,846 shares of company stock valued at $7,381,746. 3.10% of the stock is currently owned by corporate insiders.
Hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. increased its stake in Maximus by 22,491.0% in the first quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock valued at $404,518,000 after buying an additional 6,474,723 shares during the period. Clearbridge Investments LLC increased its stake in Maximus by 49.5% in the first quarter. Clearbridge Investments LLC now owns 2,004,270 shares of the health services provider’s stock valued at $124,666,000 after buying an additional 663,189 shares during the period. William Blair Investment Management LLC increased its stake in Maximus by 14.7% in the first quarter. William Blair Investment Management LLC now owns 4,416,279 shares of the health services provider’s stock valued at $274,693,000 after buying an additional 566,292 shares during the period. Norges Bank bought a new stake in Maximus during the fourth quarter valued at about $25,597,000. Finally, Columbia Wanger Asset Management LLC increased its stake in Maximus by 115.7% in the first quarter. Columbia Wanger Asset Management LLC now owns 787,691 shares of the health services provider’s stock valued at $48,994,000 after buying an additional 422,499 shares during the period. Institutional investors own 97.85% of the company’s stock.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.